In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million)
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...